Assignee
GLOBAL BLOOD THERAPEUTICS INC
US·58 granted patents·49 pending applications·827 citations·filing 2012–2024
Top patents by PatentIndex Score
107 records- 0199US10034879B2Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenationGLOBAL BLOOD THERAPEUTICS INC·Filed 2017·Granted Jul 31, 2018·36 cites·2 claims
- 0299US10017491B2Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2017·Granted Jul 10, 2018·34 cites·1 claims
- 0398US10683285B2Modulators of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2019·Granted Jun 16, 2020·31 cites·20 claims
- 0498US10450269B1Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2019·Granted Oct 22, 2019·26 cites·14 claims
- 0598US10377741B2Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenationGLOBAL BLOOD THERAPEUTICS INC·Filed 2018·Granted Aug 13, 2019·15 cites·5 claims
- 0698US9776960B2Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2015·Granted Oct 3, 2017·44 cites·15 claims
- 0798US9447071B2Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehydeGLOBAL BLOOD THERAPEUTICS INC·Filed 2015·Granted Sep 20, 2016·36 cites·33 claims
- 0898US9422279B2Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2013·Granted Aug 23, 2016·50 cites·25 claims
- 0998US9248199B21:1 adducts of sickle hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2014·Granted Feb 2, 2016·43 cites·2 claims
- 1098US9018210B2Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenationGLOBAL BLOOD THERAPEUTICS INC·Filed 2012·Granted Apr 28, 2015·56 cites·6 claims
- 1197US10137118B2Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehydeGLOBAL BLOOD THERAPEUTICS INC·Filed 2017·Granted Nov 27, 2018·20 cites·6 claims
- 1297US9957250B2Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2015·Granted May 1, 2018·19 cites·6 claims
- 1397US9802900B2Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2014·Granted Oct 31, 2017·39 cites·20 claims
- 1497US9458139B2Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2013·Granted Oct 4, 2016·45 cites·24 claims
- 1597US8952171B2Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2013·Granted Feb 10, 2015·52 cites·19 claims
- 1696US10695330B2Methods of treatmentGLOBAL BLOOD THERAPEUTICS INC·Filed 2018·Granted Jun 30, 2020·12 cites·17 claims
- 1796US9604999B2Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2013·Granted Mar 28, 2017·45 cites·3 claims
- 1895US11548880B2Modulators of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2020·Granted Jan 10, 2023·3 cites·20 claims
- 1995US10315991B2Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2017·Granted Jun 11, 2019·14 cites·3 claims
- 2094US10577345B2Process for synthesizing 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)-pyridin-3-yl)methoxy)benzaldehydeGLOBAL BLOOD THERAPEUTICS INC·Filed 2018·Granted Mar 3, 2020·12 cites·17 claims
- 2194US10435393B2Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2015·Granted Oct 8, 2019·14 cites·11 claims
- 2294US10100043B2Substituted aldehyde compounds and methods for their use in increasing tissue oxygenationGLOBAL BLOOD THERAPEUTICS INC·Filed 2014·Granted Oct 16, 2018·15 cites·26 claims
- 2394US10077249B2Process for synthesizing 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)-pyridin-3-yl)methoxy)benzaldehydeGLOBAL BLOOD THERAPEUTICS INC·Filed 2017·Granted Sep 18, 2018·24 cites·36 claims
- 2494US9012450B2Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenationGLOBAL BLOOD THERAPEUTICS INC·Filed 2012·Granted Apr 21, 2015·46 cites·14 claims
- 2593US9981939B2Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2014·Granted May 29, 2018·17 cites·7 claims
- 2692US10100040B2Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2014·Granted Oct 16, 2018·18 cites·21 claims
- 2790US10266551B2Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2014·Granted Apr 23, 2019·16 cites·21 claims
- 2890US10004725B2Methods of treatmentGLOBAL BLOOD THERAPEUTICS INC·Filed 2016·Granted Jun 26, 2018·18 cites·6 claims
- 2989US11746100B2Cycloalkyl pyrimidines as ferroportin inhibitorsGLOBAL BLOOD THERAPEUTICS INC·Filed 2021·Granted Sep 5, 2023·2 cites·48 claims
- 3088US10806733B2Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenationGLOBAL BLOOD THERAPEUTICS INC·Filed 2018·Granted Oct 20, 2020·1 cites·7 claims
- 3188US2025032471A1Crystalline Polymorphs of the Free Base of 2-Hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehydeGLOBAL BLOOD THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3287US11452720B2Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehydeGLOBAL BLOOD THERAPEUTICS INC·Filed 2020·Granted Sep 27, 2022·1 cites·14 claims
- 3387US10493035B2Tablets comprising 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehydeGLOBAL BLOOD THERAPEUTICS INC·Filed 2017·Granted Dec 3, 2019·15 cites·9 claims
- 3484US10722502B2Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehydeGLOBAL BLOOD THERAPEUTICS INC·Filed 2018·Granted Jul 28, 2020·1 cites·3 claims
- 3584US2023255963A1Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenationGLOBAL BLOOD THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3682US2022395492A1Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehydeGLOBAL BLOOD THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3780US11014884B2Modulators of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2019·Granted May 25, 2021·2 cites·60 claims
- 3879US11254651B2Histone methyltransferase inhibitorsGLOBAL BLOOD THERAPEUTICS INC·Filed 2017·Granted Feb 22, 2022·2 cites·20 claims
- 3979US2023322704A1Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4078US2025109122A1Cycloalkyl pyrimidines as ferroportin inhibitorsGLOBAL BLOOD THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 4178US2022125786A1Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenationGLOBAL BLOOD THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4277US2022135533A1Process for synthesizing 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)-pyridin-3-yl)methoxy)benzaldehydeGLOBAL BLOOD THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4376US12473277B2Solid forms of a modulator of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2023·Granted Nov 18, 2025·0 cites·22 claims
- 4476US11111243B2Azaindole compounds as histone methyltransferase inhibitorsGLOBAL BLOOD THERAPEUTICS INC·Filed 2018·Granted Sep 7, 2021·1 cites·20 claims
- 4576US2023159507A1Modulators of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4676US2023219922A1Process for synthesizing 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)-pyridin-3-yl)methoxy)benzaldehydeGLOBAL BLOOD THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4775US12202817B2Cycloalkyl pyrimidines as ferroportin inhibitorsGLOBAL BLOOD THERAPEUTICS INC·Filed 2023·Granted Jan 21, 2025·0 cites·27 claims
- 4875US11530191B2Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2020·Granted Dec 20, 2022·0 cites·4 claims
- 4975US2021290619A1Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenationGLOBAL BLOOD THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 5074US11286243B2Ferroportin inhibitors and methods of useGLOBAL BLOOD THERAPEUTICS INC·Filed 2019·Granted Mar 29, 2022·1 cites·24 claims
Showing the top 50 of 107 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when GLOBAL BLOOD THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →